Dear Valued Clients,
Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continually upgrade and refine our test menu and services, we want you to be the first to know about the changes that may affect your testing with us.
Effective May 27, 2020 in a continuing effort to optimize our offering, the following test codes will be discontinued:
Test Code |
Test Description |
21405 |
CBL Gene Sequencing by Massively Parallel Sequencing |
21410 |
RIT1 Gene Sequencing by Massively Parallel Sequencing |
22305 |
ALK Gene Sequencing by Massively Parallel Sequencing |
22315 |
MRE11A Gene Sequencing by Massively Parallel Sequencing |
22345 |
SUFU Gene Sequencing by Massively Parallel Sequencing |
22440 |
RAD50 Gene Sequencing by Massively Parallel Sequencing |
22520 |
MET Gene Sequencing by Massively Parallel Sequencing |
22530 |
WT1 Gene Sequencing by Massively Parallel Sequencing |
22605 |
CDC73 Gene Sequencing by Massively Parallel Sequencing |
22610 |
PRKAR1A Gene Sequencing by Massively Parallel Sequencing |
22615 |
TMEM127 Gene Sequencing by Massively Parallel Sequencing |
22620 |
MAX Gene Sequencing by Massively Parallel Sequencing |
22730 |
CEBPA Gene Sequencing by Massively Parallel Sequencing |
22810 |
CDK4 Gene Sequencing by Massively Parallel Sequencing |
22815 |
CDKN2A Gene Sequencing by Massively Parallel Sequencing |
If you have specific questions regarding these updates, please contact your Baylor Genetics account representative, call our Client Relations Division at 1-800-411-4363, or email us at [email protected]. For additional oncology test offerings, please visit our Test Menu.
Thank you for your continued business.
